These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 34659127)
1. Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients. Cho YY; Chung YJ; Kim HS Front Endocrinol (Lausanne); 2021; 12():745395. PubMed ID: 34659127 [TBL] [Abstract][Full Text] [Related]
3. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462 [TBL] [Abstract][Full Text] [Related]
4. Chronic Lymphocytic Thyroiditis May Limit the Utility of Molecular Testing in AUS/FLUS Thyroid Nodules. Remer LF; Linhares SM; Scola WH; Lew JI J Surg Res; 2023 Sep; 289():229-233. PubMed ID: 37148856 [TBL] [Abstract][Full Text] [Related]
5. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology. Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633 [TBL] [Abstract][Full Text] [Related]
6. Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology. Topaloglu O; Baser H; Cuhaci FN; Sungu N; Yalcin A; Ersoy R; Cakir B Endocrine; 2016 Oct; 54(1):156-168. PubMed ID: 27172917 [TBL] [Abstract][Full Text] [Related]
7. Thyroid nodules classified as atypia or follicular lesions of undetermined significance deserve further research: Analysis of 305 surgically confirmed nodules. Turkyilmaz S; Ulusahin M; Celebi B; Cekic AB; Mungan S; Kucuktulu U; Tasdelen A; Guner A; Cinel A Cytopathology; 2017 Oct; 28(5):391-399. PubMed ID: 28714532 [TBL] [Abstract][Full Text] [Related]
8. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience. Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups. García Pascual L; Surralles ML; Morlius X; Garcia Cano L; González Mínguez C Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):577-583. PubMed ID: 30262240 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance. Hong HS; Lee JY AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023 [No Abstract] [Full Text] [Related]
11. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS). Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545 [TBL] [Abstract][Full Text] [Related]
12. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines. Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972 [TBL] [Abstract][Full Text] [Related]
13. Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery. Suh YJ; Choi YJ Endocrine; 2020 Sep; 69(3):578-586. PubMed ID: 32297204 [TBL] [Abstract][Full Text] [Related]
14. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory. Rosario PW Thyroid; 2014 Jul; 24(7):1115-20. PubMed ID: 24684285 [TBL] [Abstract][Full Text] [Related]
15. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study. Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003 [TBL] [Abstract][Full Text] [Related]
16. Malignancy risk and characteristics of thyroid nodules with two consecutive results of atypia of undetermined significance or follicular lesion of undetermined significance on cytology. Park VY; Kim EK; Kwak JY; Yoon JH; Moon HJ Eur Radiol; 2015 Sep; 25(9):2601-7. PubMed ID: 25740802 [TBL] [Abstract][Full Text] [Related]
17. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy. Choi YJ; Baek JH; Ha EJ; Lim HK; Lee JH; Kim JK; Song DE; Shong YK; Hong SJ Thyroid; 2014 Mar; 24(3):494-501. PubMed ID: 23947771 [TBL] [Abstract][Full Text] [Related]
18. Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients. Arva NC; Deitch SG J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):753-60. PubMed ID: 25879311 [TBL] [Abstract][Full Text] [Related]
19. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology. Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417 [TBL] [Abstract][Full Text] [Related]
20. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP. Özkara SK; Bayrak BY; Turan G Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]